Cassava Sciences Inc vs Innodata Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Innodata Inc trades at $63.7 (market cap $2.05B). The key difference: Innodata Inc is far larger — about 42.9× Cassava Sciences Inc's market cap, and Innodata Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | INOD | |
|---|---|---|
Market Cap | $47.75M | $2.05B |
Sector | Health | Technology |
52-Week High | $4.64 | $121.50 |
52-Week Low | $0.87 | $34.45 |
Enterprise Value | -$34.93M | $1.80B |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.
The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.
No Aura AI signal available yet.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →